Associate Director Of Biology
• Directed mechanism of action studies on novel hetero bi-functional inhibitor molecules for the treatment of cancer• Established and maintain research collaborations with academic and government laboratories• Initiated and managed experimental work flows with international contract research organizations (CROs)• Prepared and managed 15+ patent portfolio of molecular therapeutics focused on targeted protein degradation (TPD), molecular chaperone inhibition, and mutant KRAS inhibition